Mr. Louis Dron reports

REDWOOD AI PROVIDES UPDATE ON ITS DEFINITIVE AGREEMENT WITH QUANTUM.IQ

Further to Redwood AI Corp.'s news releases dated May 28, 2026, and June 26, 2026, the company intends to complete the acquisition of Quantum.IQ Technologies Inc. on or about July 10, 2026, subject to the satisfaction or waiver of customary closing conditions. The acquisition will be completed pursuant to a share purchase agreement among Redwood, Quantum.IQ and the shareholders of Quantum.IQ dated June 26, 2026.

Completion of the acquisition remains subject to customary closing conditions, including receipt of all required corporate, regulatory and stock exchange approvals, execution, and delivery of the escrow agreement, the absence of any material adverse change affecting either Redwood or Quantum.IQ, and other conditions customary for a transaction of this nature. There can be no assurance that the acquisition will be completed on the terms contemplated by the purchase agreement, or at all.

The company intends to issue 50,000 common shares of the company to an arm's-length third party as an administrative fee for their assistance with the acquisition and such shares will be subject to a four-month-and-one-day hold period in accordance with applicable securities laws.

About Redwood AI Corp.

Redwood uses advanced artificial intelligence to accelerate chemistry R&D (research and development), with the aim of assisting in drug discovery and development, and furthering defence and safety solutions. The company combines expertise in chemistry, AI (artificial intelligence) and manufacturing to streamline drug synthesis and scale-up. Redwood's platform is designed to enable faster, more efficient development of new therapies and chemistry-driven applications.

We seek Safe Harbor.